The only activity that has been shown to reduce disease progression is intense exercise, and pickleball has also been shown ...

INBRIJA, a dopamine replacement therapy for off periods in Parkinson's disease, holds significant market potential due to its ability to provide rapid relief from motor symptoms. With the increasing ...

Agency supports primary and novel secondary and exploratory endpoints proposed for Phase 3 Trial(s) Opportunity to utilize ...

In her late 40s, Kirsten Macpherson struggled to get out of bed, suffering from an overwhelming feeling of anxiety. She knew ...

A clinical trial is underway in Middle Tennessee testing whether a pill can help reduce involuntary muscle movements in ...

ND0612 is an investigational drug-device therapy that provides a 24-hour continuous subcutaneous infusion of levodopa/carbidopa solution. The Food and Drug Administration (FDA) has accepted for review ...

May not respond to traditional Parkinson’s medications like levodopa. Common culprit medications include haloperidol, metoclopramide, risperidone, and flunarizine. More prominent symptoms in the ...

There is no cure for Parkinson's disease, but medications and other treatments can help replace lost dopamine and keep symptoms at bay. The most common, Levodopa, crosses the blood-brain barrier ...

GOTHENBURG, SE / ACCESS Newswire / May 28, 2025 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) - Gothenburg, Sweden, May 28, 2025 - IRLAB Therapeutics AB , a company that discovers and develops new ...